Apply for Forteo (Teriparatide) Copay Assistance Now.

Forteo (teriparatide) copay assistance refers to financial support programs — including copay cards, patient assistance programs, and nonprofit foundation grants — that help reduce the out-of-pocket cost of Forteo or generic teriparatide for eligible patients. QuickRx Specialty Pharmacy provides free enrollment support to connect osteoporosis patients with every available savings option based on their insurance coverage and financial situation. Our dedicated patient navigator team handles all application paperwork at no charge to you.

Yes — copay card programs are available for Forteo (teriparatide) for eligible patients with commercial insurance. Copay card programs can significantly reduce monthly out-of-pocket costs for teriparatide treatment. Medicare and Medicaid patients cannot use manufacturer copay cards due to federal regulations, but other options may still be available.

It is important to note that brand Forteo copay cards do not apply to generic teriparatide prescriptions — and vice versa. QuickRx patient navigators identify the correct savings program for your specific prescription — whether you are taking brand Forteo or generic teriparatide — and manage the entire enrollment process at no cost to you. Call (917) 830-2525 to get started.

Yes — patient assistance programs are available for Forteo (teriparatide) for patients who qualify based on insurance status and financial need. These programs are typically available to patients who are uninsured, underinsured, or covered by government insurance such as Medicare or Medicaid and cannot use a manufacturer copay card.

QuickRx patient navigators evaluate your specific situation, identify every available program you may qualify for, and manage the entire application process at no cost. Patient assistance programs for teriparatide may provide the medication at little or no cost for eligible patients. Call (917) 830-2525 to speak with a patient navigator about your options.

Eligibility for Forteo copay assistance varies by program type. Here is a general overview of who may qualify for each type of assistance:

QuickRx evaluates your specific coverage and identifies the programs you are most likely to qualify for at no cost. Call (917) 830-2525 to speak with a patient navigator.

No. QuickRx Specialty Pharmacy provides Forteo copay assistance enrollment support as a completely free service. There are no fees, no hidden charges, and no obligation. Our patient navigator team assists with teriparatide applications because we believe cost should never be a barrier to osteoporosis treatment.

What QuickRx Does For Free:

• Reviews your insurance coverage and identifies all available programs
• Evaluates savings options for both brand Forteo and generic teriparatide
• Completes copay card and patient assistance applications on your behalf
• Coordinates with your prescribing physician for required documentation
• Manages ongoing renewals and insurance changes
• Monitors your case to prevent any gaps in copay assistance benefits

Without insurance or copay assistance, Forteo (teriparatide) can cost over $5,000 per month — making it one of the more expensive specialty medications for osteoporosis. Generic teriparatide is available at a lower cost than brand Forteo in many cases, though pricing varies by pharmacy and insurance formulary.

Factors That Affect Your Teriparatide Cost:

• Brand vs. generic: Generic teriparatide is typically available at a lower cost than brand Forteo, though this varies
• Insurance coverage: Most commercial plans cover teriparatide for eligible osteoporosis patients, with varying copay amounts
• Formulary tier: Whether brand Forteo or generic teriparatide is preferred on your plan’s formulary affects your copay
• Copay assistance enrollment: Eligible patients enrolled in savings programs may significantly reduce their out-of-pocket costs

Contact QuickRx at (917) 830-2525 for a free benefits review to explore all available savings options for your specific situation.

Medicare patients cannot use manufacturer copay cards due to federal regulations. However, other financial assistance options may still be available for Forteo or generic teriparatide.

Options for Medicare Patients:

• Patient assistance programs: May provide teriparatide at reduced or no cost based on financial need
• Osteoporosis foundation grants: Nonprofit organizations focused on bone health may offer financial assistance regardless of insurance type
• Generic teriparatide: May be covered at a lower cost tier under your Medicare Part D plan compared to brand Forteo
• Medicare Extra Help / Low-Income Subsidy: May help reduce specialty drug costs for qualifying patients
• State pharmaceutical assistance programs: Availability varies by state

QuickRx patient navigators can review your specific Medicare coverage and identify all available options at no cost. Call (917) 830-2525.

Yes — generic teriparatide is available in the United States. Generic teriparatide contains the same active ingredient at the same strength as brand Forteo and is administered the same way — as a once-daily subcutaneous injection using a prefilled pen injector.

Whether brand Forteo or generic teriparatide is appropriate for you depends on your insurance formulary, your prescriber’s preference, and your specific clinical situation. An important note: brand Forteo copay savings programs do not apply to generic teriparatide — patients on generic teriparatide need separate savings program enrollment. QuickRx patient navigators can help identify and enroll you in the right program for your prescription. Call (917) 830-2525 for a free benefits review.

Forteo (teriparatide) is a recombinant formulation of parathyroid hormone (PTH) used to treat osteoporosis in patients at high risk for fracture. Unlike most osteoporosis medications that work by slowing bone loss, teriparatide works by stimulating new bone formation — making it one of the few anabolic (bone-building) treatments available.

FDA-Approved Indications:

• Postmenopausal women at high risk for fracture: Including those with a history of osteoporotic fracture or multiple risk factors for fracture
• Men with primary or hypogonadal osteoporosis at high risk for fracture
• Glucocorticoid-induced osteoporosis: In patients taking prednisone ≥5 mg/day (or equivalent) at high risk for fracture

Teriparatide may also be used in patients who are intolerant to other available osteoporosis therapies or in whom other therapies have failed.

Forteo (teriparatide) is administered as a once-daily subcutaneous injection using a prefilled pen injector. The standard dose is 20 mcg injected once daily.

Administration Details:

• Inject into the thigh or abdominal wall
• May be administered without regard to meals or time of day
• May administer immediately following removal from the refrigerator
• Each teriparatide delivery pen can be used for up to 28 days after the first injection
• Initial administration should occur while sitting or lying down, in case of dizziness (orthostatic hypotension)

Important Administration Notes:

• Do not share your pen device with another person — even if the needle is changed — due to infection risk
• Discard the pen 28 days after first use, even if solution remains
• Do not use if the solution is cloudy, colored, or contains particles

Always follow your healthcare provider’s specific instructions for administration.

Teriparatide therapy should generally not exceed 2 cumulative years due to limited data with use beyond this duration. Fracture reduction efficacy has been demonstrated over periods of 18 to 36 months.

Use beyond 2 cumulative years should only be considered in select patients who remain at or return to high fracture risk, as determined by their healthcare provider.

After Completing Teriparatide:

• Following a course of teriparatide, switching to antiresorptive therapy (such as a bisphosphonate) is typically recommended to maintain bone density gains
• Bone density gains may reverse without follow-up therapy in some patients
• Your prescriber will develop an individualized plan for therapy after teriparatide

If you need help affording Forteo throughout your treatment period, QuickRx patient navigators manage copay assistance renewals at no charge. Call (917) 830-2525.

Most common side effects of teriparatide are mild to moderate and include dizziness, nausea, and joint pain.

Common Side Effects (reported in clinical trials):

• Hypercalcemia (elevated calcium) — 11% in females, 6% in males
• Nausea — 9% to 14%
• Dizziness — 8%
• Headache — 8%
• Asthenia (weakness/fatigue) — 9%
• Arthralgia (joint pain) — 10%
• Rhinitis (runny nose) — 10%
• Leg cramps — 3%
• Orthostatic hypotension (dizziness when standing) — transient, frequency not defined

Talk to your healthcare provider about any side effects that concern you or that do not improve.

Patients and prescribers should be aware of the following important warnings before and during teriparatide therapy.

Important Forteo Warnings:

• Osteosarcoma (bone cancer): Postmarketing reports of osteosarcoma have been received, though an increased risk has not been confirmed in observational studies. Avoid use in patients at increased baseline risk for osteosarcoma (including those with open epiphyses, Paget disease of bone, bone metastases, history of skeletal malignancies, or prior skeletal radiation therapy).
• Hypercalcemia: Teriparatide may increase serum calcium levels. Use with caution in patients with a history of hypercalcemia or hypercalcemic disorders such as primary hyperparathyroidism.
• Orthostatic hypotension: May cause transient dizziness or lightheadedness, typically within 4 hours of dosing and during the first several doses. Initial injections should be given while sitting or lying down.
• Urolithiasis (kidney stones): Use with caution in patients with active or recent kidney stones, as teriparatide may exacerbate this condition.
• Cutaneous calcification: Serious worsening of skin calcification has been reported rarely, particularly in patients with autoimmune disease, kidney failure, or those taking warfarin or corticosteroids.

This information is for educational purposes only. Always review all risks with your prescribing healthcare provider before starting teriparatide.

Proper storage of teriparatide is essential to maintain medication integrity and effectiveness.

Forteo Storage Instructions:

• Store refrigerated at 36°F to 46°F (2°C to 8°C)
• Do not freeze — discard the pen if freezing occurs
• Protect from light
• Discard the pen 28 days after the first injection, even if solution remains in the pen
• Do not use if the solution is cloudy, colored, or contains solid particles
• The pen may be administered immediately after removing from the refrigerator

If you have questions about storing your teriparatide pen, contact your QuickRx pharmacist at (917) 830-2525.

Ensuring adequate calcium and vitamin D intake is important during teriparatide therapy to support bone building and avoid deficiency. If dietary intake is inadequate, supplementation is recommended — but use caution to avoid hypercalcemia (elevated calcium).

Recommended Intake During Teriparatide Therapy:

• Calcium: 1,000 mg/day (men aged 50–70) or 1,200 mg/day (women ≥51 years and men ≥71 years). Some clinicians suggest limiting calcium to ≤1,000 mg/day in patients taking teriparatide — discuss with your prescriber.
• Vitamin D: 800 to 1,000 IU/day for patients age 50 and older

Correct any vitamin D deficiency (to a 25-hydroxyvitamin D level ≥20 ng/mL) before starting teriparatide therapy. Discuss your specific calcium and vitamin D needs with your prescriber.

Teriparatide is not appropriate for everyone. Certain patients should avoid or use it with caution.

Avoid Teriparatide If You Have:

• Known hypersensitivity (allergy) to teriparatide or any component of the formulation
• Preexisting hypercalcemia or a hypercalcemic disorder (eg, primary hyperparathyroidism) — avoid until fully resolved
• Open growth plates (pediatric patients or young adults)
• Paget disease of the bone or other metabolic bone diseases other than primary osteoporosis
• History of bone metastases or skeletal malignancies
• Prior external beam or implant radiation therapy to the skeleton

Use With Caution If You Have:

• Active or recent kidney stones (urolithiasis)
• Severe renal impairment (eGFR less than 30 mL/min) — use only if at very high fracture risk and under nephrology guidance
• Autoimmune disease, kidney failure, or if taking warfarin or corticosteroids (increased risk of cutaneous calcification)

Pregnancy and Breastfeeding:

• Avoid use in patients who are pregnant or planning to become pregnant
• Effective contraception is required during treatment for patients who could become pregnant
• Breastfeeding is not recommended during teriparatide therapy

Always discuss your full medical history with your prescriber before starting teriparatide.

Yes. QuickRx Specialty Pharmacy is licensed to dispense and ship Forteo (teriparatide) and generic teriparatide to patients in all 50 states. We provide free home delivery and ensure medications are properly packaged with temperature-controlled shipping to maintain refrigeration integrity.

Why Patients Choose QuickRx for Forteo:

• Nationwide shipping to all 50 states
• Temperature-controlled delivery to maintain teriparatide refrigeration requirements
• Free copay assistance enrollment for both brand Forteo and generic teriparatide
• Dedicated patient navigators specializing in osteoporosis and bone health
• Prior authorization support and appeal assistance
• URAC- and ACHC-accredited specialty pharmacy
• Ongoing case monitoring to prevent gaps in copay assistance benefits

Call us at (917) 830-2525 or complete the form on this page to get started today.